Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Molecular Devices ChinaMolecular Devices China
VS
BioconBiocon
Molecular Devices China

Molecular Devices China

长宁区福泉北路, 上海, 200335, CN

Last Update: 01/12/2025

View Profile
751/1000Fair

Molecular Devices始创于上世纪80年代美国硅谷,作为全球高通量仪器设备的优秀品牌,一直致力于为生命科学研究及药物研发提供先进的解决方案。其产品覆盖微孔板检测分析、高通量筛选、高内涵成像、高效克隆筛选等。公司以持续创新、快速高效、高质量的产品及完善的售后服务著称业内。 Molecular Devices为您提供高性能的分析检测系统,加快和改进药物研发及基础生命科学的研究。我们的产品除了用于科研单位和部门外,还帮助制药和生物技术企业从分子、细胞和系统水平去了解各项生物功能,研究开发新的治疗方法。 Molecular Dev...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:67
12-month incidents
0
Known data breaches
0
Attack type number
0
Biocon

Biocon

Hosur Road, Electronics City, Bangalore, Karnataka, IN, 560100

Last Update: 12/09/2026

View Profile
Between 750 and 799
http://www.biocon.com
773/1000Fair

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:11,558
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Molecular Devices China

Molecular Devices China

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Biocon

Biocon

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Molecular Devices China in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biocon in 2026.

Incidents

Incident History - Molecular Devices China (X = Date, Y = Severity)

Molecular Devices China cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Biocon (X = Date, Y = Severity)

Biocon cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Molecular Devices China

Molecular Devices China

Incidents
No explicit notable incidents reported.
Biocon

Biocon

Incidents
No explicit notable incidents reported.

FAQ

Between Molecular Devices China company and Biocon company, which one has the best AI Cybersecurity Score ?
Between Molecular Devices China company and Biocon company, which one has experienced more cyber incidents in the past ?
Between Molecular Devices China company and Biocon company, which one has experienced more cyber incidents this year ?
Between Molecular Devices China company and Biocon company, which one has experienced at least one ransomware attack ?
Between Molecular Devices China company and Biocon company, which one has experienced at least one data breach ?
Between Molecular Devices China company and Biocon company, which one has experienced at least one targeted cyberattack ?
Between Molecular Devices China company and Biocon company, which one has experienced at least one vulnerability ?
Between Molecular Devices China company and Biocon company, which one holds the most compliance certifications ?
Between Molecular Devices China company and Biocon company, which one holds the fewest compliance certifications ?
Between Molecular Devices China company and Biocon company, which one has the most subsidiaries ?
Between Molecular Devices China company and Biocon company, which one has the largest number of employees ?
Between Molecular Devices China and Biocon, which company holds both SOC 2 Type 1 certifications ?
Between Molecular Devices China and Biocon, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Molecular Devices China or Biocon ?
Which company is PCI DSS compliant - Molecular Devices China or Biocon ?
Between Molecular Devices China and Biocon, which company complies with HIPAA regulations for healthcare data ?
Between Molecular Devices China and Biocon, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-95828
SUMMARY

A vulnerability was determined in Mstfakts College-Management-System. This affects the function session_start of the file Front-end/server.php of the component Authentication. Executing a manipulation can lead to session fixiation. It is possible to launch the attack remotely. The exploit has been publicly disclosed and may be utilized. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 4.3)
CVSS2
Base Score: 5.0
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:N/A:N
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-95820
SUMMARY

A vulnerability was found in anirbandutta9 College-Notes-Gallery up to 8c1cf3d98f30982d069c88ca172612c001eb39f6. Affected by this issue is some unknown functionality of the file /dashboard/userprofile.php?section=admin1. Performing a manipulation of the argument image results in unrestricted upload. It is possible to initiate the attack remotely. The exploit has been made public and could be used. This product is using a rolling release to provide continious delivery. Therefore, no version details for affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-61685
SUMMARY

ReactPress is a publishing system for React developers. Prior to version 3.7.0, ReactPress API list endpoints build TypeORM `QueryBuilder` conditions using unsanitized HTTP query parameter names as SQL column identifiers (e.g. `` `article.${key}` ``). TypeORM parameterizes values but not column names, allowing unauthenticated attackers to inject SQL through crafted query string keys. Version 3.7.0 contains a patch. As a workaround, allowlist allowed filter column names before interpolating into SQL.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-57576
SUMMARY

plone.app.dexterity is a content-type system for the Plone content management system, and plone.app.contenttypes provides Plone’s Dexterity-based content types. Plone.app.dexterity versions through 3.2.2, 4.0.0 through 4.1.2, and 5.0.0, and plone.app.contenttypes versions through 3.0.11, 4.0.0 through 4.0.9, and 5.0.0 are vulnerable to denial of service because an authenticated user can create content with excessively long titles, descriptions, or uploaded-file names, causing Plone to become unresponsive and potentially making the resulting content difficult to edit or delete. The vulnerability is patched in plone.app.dexterity versions 3.2.3, 4.1.3, and 5.0.1, and in plone.app.contenttypes versions 3.0.12, 4.0.10, and 5.0.1.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-18176
SUMMARY

IBM Financial Transaction Manager (FTM) for RedHat OpenShift could allow a remote attacker to obtain sensitive information due to cleartext transmission of sensitive information.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: LOW
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
IMPACT SCORE
4
EXPLOITABILITY
2.8